rfhg_82360.1

Basic information about the TSS

---

TSS ID: rfhg_82360.1 TSS ID(Version3): hg_73466.1 hg_229956.1 hg_73465.1 Species: human Chr: chr6		Start: 38703070 End: 38703178 Strand: -
Source datasets	FANTOM5|PRJNA4843412|DRA013844|PRJDB5282|PRJNA401781 |PRJNA548673|PRJNA615891|PRJNA597322
Protocol	CAGE|NETCAGE|C1CAGE|oligo_capping|SLIC_CAGE|ReCappable-seq |TIF-seq2|RAMPAGE|STRIPE-seq
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3838992,EH38E2465206)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000373365.5:0 BC011365:0 D13315:0 FJ224325:0 BC015934:0 BC001741:0 AK130312:0 AK129573:0 AL833442:0 AK293345:0 L07837:0 AK312662:0 GeneID: 2739 HGNC/MGI_ID: HGNC:4323 UniProt_ID: V9HW62 X5DNM4 Nearer transcript ids and distances:

Gene_name: GLO1 Gene_symbol: GLO1 Gene_synonyms: GLOD1 Gene_source: HGNC:4323

TATA-Box annotation

---

Distance to TSS:	21
Nearest PromoterID:	NM_006708
Entrez ID:	2739
Nearest Unigene:	Hs.268849
Nearest Refseq:	NM_006708
Nearest Ensembl:	ENSG00000124767
Gene Name:	GLO1
Gene Alias:	GLOD1|GLYI|HEL-S-74
Gene Type:	protein-coding
CpG%:	0.120370
GC%:	0.669725
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GLO1 p2@GLO1
Sample		p1@GLO1	p2@GLO1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	286.17	100.91
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	304.29	99.74
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	298.23	98.38
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	233.69	89.40
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	253.09	102.58
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	252.53	102.53
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	393.06	153.17
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	291.15	116.27
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	296.00	114.98
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	215.62	68.40
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	190.80	67.91
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	193.93	55.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	75.44	25.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	73.52	24.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	74.65	22.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	65.14	27.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	73.82	23.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	61.16	25.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	65.04	18.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	74.32	21.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	78.05	21.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	76.82	24.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	71.48	23.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	69.16	20.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	76.36	23.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	74.38	23.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	70.88	23.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	86.29	28.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	79.95	25.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	75.82	27.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	73.48	24.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	75.22	32.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	69.64	23.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	95.17	34.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	74.05	25.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	75.88	26.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	80.93	26.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	75.56	23.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	81.03	28.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	90.02	27.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	75.75	20.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	98.52	36.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	75.29	24.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	79.02	23.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	90.75	30.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	82.12	28.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	68.61	23.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	71.23	28.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	74.68	19.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	73.20	27.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	79.93	23.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	87.84	29.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	587.67	83.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	80.91	28.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	73.24	22.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	209.73	57.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	119.86	34.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	78.11	23.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	72.91	20.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	128.88	27.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	65.57	19.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	57.76	22.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	120.22	35.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	76.79	20.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	54.91	18.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	64.96	17.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	274.79	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	363.28	55.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	86.29	31.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	86.78	25.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	107.90	27.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	145.06	34.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	113.22	30.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	107.93	33.02
Adipocyte - breast, donor1	11376-118A8	73.33	33.74
Adipocyte - breast, donor2	11327-117E4	51.66	25.19
Adipocyte - omental, donor1	11473-119C6	73.03	38.80
Adipocyte - omental, donor2	11474-119C7	56.81	24.67
Adipocyte - omental, donor3	11475-119C8	57.27	18.76
Adipocyte - perirenal, donor1	11476-119C9	66.35	29.35
Adipocyte - subcutaneous, donor1	11259-116F8	24.19	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	92.58	24.84
Adipocyte - subcutaneous, donor3	11408-118E4	51.79	19.81
Adipocyte differentiation, day04, donor1	13019-139D4	71.19	25.03
Adipocyte differentiation, day04, donor2	13022-139D7	49.16	14.16
Adipocyte differentiation, day04, donor3	13025-139E1	73.87	22.86
Adipocyte differentiation, day04, donor4	13028-139E4	68.19	26.45
Adipocyte differentiation, day08, donor1	13020-139D5	84.45	41.26
Adipocyte differentiation, day08, donor2	13023-139D8	47.44	21.62
Adipocyte differentiation, day08, donor3	13026-139E2	58.12	14.40
Adipocyte differentiation, day08, donor4	13029-139E5	50.64	23.93
Adipocyte differentiation, day12, donor1	13021-139D6	63.63	43.67
Adipocyte differentiation, day12, donor2	13024-139D9	46.21	23.36
Adipocyte differentiation, day12, donor3	13027-139E3	45.49	24.54
Adipocyte differentiation, day12, donor4	13030-139E6	36.84	26.18
Alveolar Epithelial Cells, donor1	11510-119G7	80.44	22.54
Alveolar Epithelial Cells, donor2	11590-120G6	7.53	3.94
Alveolar Epithelial Cells, donor3	11671-122G6	10.78	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	47.67	13.13
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	29.79	9.66
Anulus Pulposus Cell, donor1	11248-116E6	93.26	35.82
Anulus Pulposus Cell, donor2	11463-119B5	71.02	22.78
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	50.32	17.97
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	58.17	16.93
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	62.07	14.98
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	55.60	19.43
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	69.56	16.44
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	55.45	22.44
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	47.43	14.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	50.00	13.11
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	54.64	19.60
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	56.87	18.08
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	52.25	17.42
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	36.36	11.28
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	68.04	24.88
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	39.58	19.11
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	70.57	22.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	59.47	17.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	54.79	21.16
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	53.72	20.85
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	46.82	17.56
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	50.59	19.57
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	57.63	18.01
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	70.80	14.16
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	58.83	16.12
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	16.78
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	50.00	20.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	49.33	16.70
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	50.88	20.59
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	57.00	18.81
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	51.52	20.31
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	52.65	22.20
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	47.86	14.08
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	51.45	21.87
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	45.66	11.42
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	62.00	14.62
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	52.39	19.57
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	64.15	17.82
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	61.03	15.77
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	52.21	16.30
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	39.39	15.25
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	41.43	19.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	54.62	18.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	49.30	20.01
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	50.07	15.12
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	47.30	24.41
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	50.96	20.85
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	48.59	12.68
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	52.96	16.08
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	51.14	19.25
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	61.23	14.58
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	51.49	16.55
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	66.31	20.40
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	74.49	23.64
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	56.15	20.23
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	50.49	21.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	54.49	18.16
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	50.33	18.40
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	50.35	16.78
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	50.40	16.62
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	53.49	17.21
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	43.61	19.99
Astrocyte - cerebellum, donor1	11500-119F6	70.37	15.60
Astrocyte - cerebellum, donor2	11580-120F5	30.47	9.41
Astrocyte - cerebellum, donor3	11661-122F5	14.26	3.15
Astrocyte - cerebral cortex, donor1	11235-116D2	160.70	51.59
Astrocyte - cerebral cortex, donor2	11316-117D2	167.60	51.28
Astrocyte - cerebral cortex, donor3	11392-118C6	177.05	58.62
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	146.80	25.35
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	141.57	30.07
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	139.06	25.83
Basophils, donor1	12241-129G9	24.58	8.11
Basophils, donor2	12242-129H1	38.97	16.24
Basophils, donor3	12243-129H2	24.84	5.59
Bronchial Epithelial Cell, donor1	11511-119G8	27.38	5.61
Bronchial Epithelial Cell, donor2	11591-120G7	9.60	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	114.78	28.69
Bronchial Epithelial Cell, donor4	11453-119A4	84.11	36.40
Bronchial Epithelial Cell, donor5	11457-119A8	50.74	12.48
Bronchial Epithelial Cell, donor6	11461-119B3	45.83	6.91
Bronchial Epithelial Cell, donor7	11769-123I5	99.87	17.45
Burkitt's lymphoma cell line:DAUDI	10422-106C8	109.65	23.08
Burkitt's lymphoma cell line:RAJI	10476-106I8	346.79	69.64
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	98.49	29.74
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	0.00
CD14+ Monocytes, donor1	11224-116B9	18.60	6.20
CD14+ Monocytes, donor2	11305-117B9	20.42	5.75
CD14+ Monocytes, donor3	11381-118B4	18.66	7.90
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	64.82	21.79
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	68.61	28.43
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	53.58	18.08
CD14+ monocytes - mock treated, donor1	11863-125A9	16.77	6.65
CD14+ monocytes - mock treated, donor2	11873-125C1	22.33	19.01
CD14+ monocytes - mock treated, donor3	11883-125D2	17.53	9.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	12.89	3.52
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	18.22	8.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	15.87	3.97
CD14+ monocytes - treated with BCG, donor1	11860-125A6	11.94	4.70
CD14+ monocytes - treated with BCG, donor2	11870-125B7	15.49	4.99
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.72	4.57
CD14+ monocytes - treated with Candida, donor1	11868-125B5	13.35	6.56
CD14+ monocytes - treated with Candida, donor2	11878-125C6	26.93	8.45
CD14+ monocytes - treated with Candida, donor3	11888-125D7	6.66	6.66
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	12.64	4.61
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.36	8.18
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	21.24	5.41
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	11.67	4.12
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	21.04	6.56
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	15.28	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.33	3.23
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	21.11	9.94
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	18.94	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	8.63	2.20
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	14.80	4.93
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.97	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	14.47	3.66
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	19.33	4.46
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	26.94	5.39
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.83	3.69
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	23.41	5.33
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	16.01	4.41
CD14+CD16+ Monocytes, donor1	11789-124B7	44.25	11.12
CD14+CD16+ Monocytes, donor2	11801-124D1	44.81	10.16
CD14+CD16+ Monocytes, donor3	11912-125G4	43.97	11.91
CD14+CD16- Monocytes, donor1	11788-124B6	38.31	9.03
CD14+CD16- Monocytes, donor2	11799-124C8	37.55	7.68
CD14+CD16- Monocytes, donor3	11910-125G2	40.58	7.80
CD14-CD16+ Monocytes, donor1	11790-124B8	41.08	8.42
CD14-CD16+ Monocytes, donor2	11800-124C9	51.60	8.34
CD14-CD16+ Monocytes, donor3	11911-125G3	50.74	8.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	93.49	46.74
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	86.78	42.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	98.38	43.50
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	102.34	65.56
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	133.48	64.86
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	102.48	44.92
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	78.44	36.08
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	101.51	55.37
CD19+ B Cells, donor1	11544-120B5	83.83	30.41
CD19+ B Cells, donor2	11624-122B4	66.74	17.41
CD19+ B Cells, donor3	11705-123B4	69.67	23.22
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	178.19	21.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	155.00	16.78
CD34+ Progenitors, donor1	11545-120B6	47.19	21.09
CD34+ Progenitors, donor2	11625-122B5	50.00	17.42
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	90.56	26.30
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	119.51	30.67
CD4+ T Cells, donor1	11225-116C1	57.49	20.35
CD4+ T Cells, donor2	11306-117C1	54.50	15.31
CD4+ T Cells, donor3	11382-118B5	49.41	15.86
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	77.85	28.59
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	59.97	16.84
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	64.97	24.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	63.05	24.65
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	59.00	21.77
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	42.85	23.07
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	200.30	155.93
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	86.43	51.18
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	125.74	96.08
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	58.73	14.35
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	57.30	22.71
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	56.76	11.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	146.73	70.41
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	98.28	56.72
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	133.32	96.23
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	51.12	22.03
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	57.88	17.15
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	55.59	19.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	195.44	124.61
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	140.58	74.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	188.72	130.08
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	61.18	20.73
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	48.52	17.76
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	66.68	23.97
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	63.84	46.52
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	52.62	48.93
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	67.00	34.90
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	79.20	44.59
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	89.57	56.19
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	72.38	35.42
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	63.39	38.68
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	88.64	37.39
CD8+ T Cells, donor1	11226-116C2	39.61	23.57
CD8+ T Cells, donor2	11307-117C2	43.93	13.52
CD8+ T Cells, donor3	11383-118B6	50.25	21.71
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	57.58	17.66
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	46.25	21.33
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	47.88	22.43
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	71.45	22.22
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	55.44	18.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	56.85	19.33
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	64.53	27.16
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	67.38	25.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	68.95	27.44
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	84.83	30.79
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	73.79	31.08
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	84.46	22.11
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	56.91	15.76
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	46.45	20.95
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.02	16.41
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	50.42	18.37
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	50.35	21.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	45.02	22.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	80.81	26.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	80.27	29.53
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	76.30	22.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	73.43	31.74
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	53.60	24.83
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	77.15	20.42
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	36.13	17.67
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	47.56	16.09
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	72.13	23.04
Cardiac Myocyte, donor1	11525-119I4	27.42	23.76
Cardiac Myocyte, donor2	11605-120I3	68.68	15.32
Cardiac Myocyte, donor3	11686-122I3	113.86	26.41
Chondrocyte - de diff, donor1	11261-116G1	126.88	29.47
Chondrocyte - de diff, donor2	11338-117F6	51.17	23.81
Chondrocyte - de diff, donor3	11410-118E6	59.05	26.06
Chondrocyte - re diff, donor2	11339-117F7	88.63	24.17
Chondrocyte - re diff, donor3	11411-118E7	42.87	11.73
Ciliary Epithelial Cells, donor1	11242-116D9	171.79	50.72
Ciliary Epithelial Cells, donor2	11323-117D9	130.61	53.87
Ciliary Epithelial Cells, donor3	11399-118D4	122.39	48.85
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	49.52	26.68
Corneal Epithelial Cells, donor1	11526-119I5	19.76	5.05
Corneal Epithelial Cells, donor2	11606-120I4	22.75	5.69
Corneal Epithelial Cells, donor3	11687-122I4	30.93	6.90
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	27.57	16.51
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	30.28	17.66
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	20.70
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	27.32	16.41
Dendritic Cells - plasmacytoid, donor1	11228-116C4	82.68	39.63
Dendritic Cells - plasmacytoid, donor2	11309-117C4	116.21	50.27
Dendritic Cells - plasmacytoid, donor3	11385-118B8	103.56	34.84
Endothelial Cells - Aortic, donor0	11207-116A1	63.71	15.01
Endothelial Cells - Aortic, donor1	11263-116G3	55.16	18.19
Endothelial Cells - Aortic, donor2	11340-117F8	59.10	17.25
Endothelial Cells - Aortic, donor3	11412-118E8	46.40	15.73
Endothelial Cells - Artery, donor1	11264-116G4	39.85	17.16
Endothelial Cells - Artery, donor2	11341-117F9	76.94	24.47
Endothelial Cells - Artery, donor3	11413-118E9	63.81	17.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	57.41	21.72
Endothelial Cells - Lymphatic, donor2	11317-117D3	78.20	27.69
Endothelial Cells - Lymphatic, donor3	11393-118C7	63.43	21.14
Endothelial Cells - Microvascular, donor1	11265-116G5	73.09	16.64
Endothelial Cells - Microvascular, donor2	11342-117G1	66.65	17.18
Endothelial Cells - Microvascular, donor3	11414-118F1	30.77	8.93
Endothelial Cells - Thoracic, donor1	11266-116G6	117.64	21.61
Endothelial Cells - Thoracic, donor2	11343-117G2	46.65	10.48
Endothelial Cells - Umbilical vein, donor1	11243-116E1	172.08	55.41
Endothelial Cells - Umbilical vein, donor2	11324-117E1	90.82	28.03
Endothelial Cells - Umbilical vein, donor3	11400-118D5	101.73	28.09
Endothelial Cells - Vein, donor1	11267-116G7	53.46	17.06
Endothelial Cells - Vein, donor2	11344-117G3	50.99	15.37
Endothelial Cells - Vein, donor3	11416-118F3	92.16	38.47
Eosinophils, donor1	12244-129H3	45.74	15.25
Eosinophils, donor2	12245-129H4	14.85	4.95
Eosinophils, donor3	12246-129H5	10.70	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	18.57	4.15
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	64.04	34.48
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	47.30	23.32
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	68.58	29.90
Fibroblast - Aortic Adventitial, donor1	11245-116E3	90.11	32.62
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	54.18	21.15
Fibroblast - Aortic Adventitial, donor2	11326-117E3	62.44	23.41
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	32.15	7.90
Fibroblast - Aortic Adventitial, donor3	11401-118D6	87.37	28.90
Fibroblast - Cardiac, donor1	11268-116G8	72.58	20.87
Fibroblast - Cardiac, donor2	11345-117G4	54.57	8.34
Fibroblast - Cardiac, donor3	11417-118F4	32.17	13.25
Fibroblast - Cardiac, donor4	11452-119A3	87.30	27.28
Fibroblast - Cardiac, donor5	11456-119A7	96.95	30.08
Fibroblast - Cardiac, donor6	11460-119B2	114.00	35.93
Fibroblast - Choroid Plexus, donor1	11492-119E7	59.22	17.82
Fibroblast - Choroid Plexus, donor2	11572-120E6	65.58	18.12
Fibroblast - Choroid Plexus, donor3	11653-122E6	162.59	35.16
Fibroblast - Conjunctival, donor1	11531-120A1	29.06	5.54
Fibroblast - Conjunctival, donor3	11692-122I9	107.53	35.96
Fibroblast - Dermal, donor1	11269-116G9	97.90	23.71
Fibroblast - Dermal, donor2	11346-117G5	82.54	18.87
Fibroblast - Dermal, donor3	11418-118F5	115.69	29.86
Fibroblast - Dermal, donor4	11450-119A1	191.16	47.59
Fibroblast - Dermal, donor5	11454-119A5	213.71	53.73
Fibroblast - Dermal, donor6	11458-119A9	255.00	63.51
Fibroblast - Gingival, donor1	11237-116D4	102.45	36.44
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	74.15	17.03
Fibroblast - Gingival, donor2	11318-117D4	155.77	39.01
Fibroblast - Gingival, donor3	11394-118C8	70.77	28.43
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	81.03	6.23
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	51.10	13.57
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	132.04	25.72
Fibroblast - Gingival, donor6 (control)	11922-125H5	111.02	25.15
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	36.35	8.12
Fibroblast - Gingival, donor7 (control)	11924-125H7	111.00	31.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	117.13	26.18
Fibroblast - Gingival, donor8 (control)	11926-125H9	127.79	27.31
Fibroblast - Gingival, donor9 (control)	11927-125I1	77.04	21.57
Fibroblast - Lung, donor1	11270-116H1	54.37	10.87
Fibroblast - Lung, donor2	11347-117G6	107.44	19.40
Fibroblast - Lung, donor3	11419-118F6	120.29	30.81
Fibroblast - Lymphatic, donor1	11506-119G3	29.16	10.83
Fibroblast - Lymphatic, donor2	11586-120G2	27.97	19.58
Fibroblast - Lymphatic, donor3	11667-122G2	4.48	1.40
Fibroblast - Mammary, donor1	11540-120B1	62.11	19.49
Fibroblast - Mammary, donor2	11620-122A9	19.97	3.99
Fibroblast - Mammary, donor3	11701-123A9	59.56	17.87
Fibroblast - Periodontal Ligament, donor1	11238-116D5	216.28	45.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	192.48	42.17
Fibroblast - Periodontal Ligament, donor3	11395-118C9	128.21	49.88
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	79.76	19.84
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	75.60	27.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	54.86	14.50
Fibroblast - Pulmonary Artery, donor1	11250-116E8	129.99	51.62
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	42.67	7.72
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	30.74	5.35
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	107.93	30.44
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	58.34	13.49
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	88.63	18.83
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	111.55	25.42
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	47.23	11.43
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	115.94	27.96
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	57.95	14.68
Fibroblast - skin normal, donor1	11553-120C5	89.91	23.30
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	65.16	12.83
Fibroblast - skin normal, donor2	11561-120D4	112.62	29.23
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	74.05	17.83
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	100.66	26.01
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	104.28	30.94
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	39.74	13.14
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	131.45	30.36
Fibroblast - skin walker warburg, donor1	11554-120C6	121.62	26.48
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	87.51	29.33
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	709.11	332.40
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	93.25	60.14
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	158.80	90.49
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	138.97	92.65
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	130.31	71.54
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	208.23	65.07
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	247.57	74.65
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	387.96	104.98
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	260.59	44.40
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	165.99	44.98
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	258.56	73.31
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	246.36	38.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	182.97	50.55
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	385.18	91.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	204.35	48.19
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	157.87	34.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	161.44	42.17
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	174.81	33.82
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	208.33	36.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	148.61	35.78
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	117.28	26.93
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	153.71	30.39
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	127.87	22.08
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	128.83	26.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	163.57	29.41
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	130.92	28.37
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	129.85	31.05
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	160.65	41.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	165.37	44.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	123.72	29.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	126.20	24.93
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	136.21	33.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	162.65	42.93
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	141.29	38.59
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	126.05	29.50
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	142.27	33.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	113.90	25.18
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	109.33	25.79
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	141.19	32.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	122.70	35.01
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	101.99	22.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	120.62	30.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	105.66	28.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	119.20	20.98
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	112.80	32.41
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	114.83	25.03
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	105.21	25.53
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	103.05	31.57
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	119.80	39.58
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	114.91	36.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	134.98	44.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	113.04	38.76
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	93.65	35.21
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	85.53	28.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	73.39	35.70
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	104.34	26.78
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	98.46	27.64
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	84.38	25.16
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	269.33	68.87
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	201.22	43.91
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	257.16	58.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	289.77	85.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	293.86	84.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	289.64	71.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	264.80	108.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	241.37	82.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	242.27	78.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	213.88	52.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	224.26	69.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	209.61	72.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	166.61	53.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	218.68	66.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	214.41	58.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	203.84	57.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	221.38	69.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	231.65	72.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	344.54	91.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	286.35	74.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	214.00	45.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	203.30	108.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	232.37	90.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	199.75	71.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	252.89	84.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	224.88	65.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	237.96	81.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	268.87	98.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	249.65	52.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	215.33	53.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	298.17	52.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	288.30	55.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	246.23	39.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	284.86	60.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	266.03	67.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	247.66	63.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	270.32	40.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	284.72	55.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	251.04	48.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	229.73	44.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	185.04	41.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	171.78	60.66
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	45.65	6.85
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	48.65	11.23
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	59.60	11.24
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	69.78	24.10
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	57.23	33.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	130.43	42.94
Hep-2 cells mock treated, biol_rep2	11899-125E9	159.85	43.72
Hep-2 cells mock treated, biol_rep3	11900-125F1	154.93	40.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	126.80	46.57
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	157.10	45.99
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	146.82	35.52
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	141.97	48.82
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	149.25	45.46
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	143.53	37.80
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	44.21	11.19
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	10.39	2.16
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	74.03	18.51
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	27.51	13.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	14.53	10.17
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	117.14	33.04
Hepatocyte, donor1	11523-119I2	101.69	24.21
Hepatocyte, donor2	11603-120I1	107.73	16.16
Hepatocyte, donor3	11684-122I1	95.71	29.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	138.37	44.38
Intestinal epithelial cells (polarized), donor1	11246-116E4	102.95	55.23
Iris Pigment Epithelial Cells, donor1	11530-119I9	121.98	36.36
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	74.76	5.54
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	52.56	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	66.64	7.69
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	94.21	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	80.03	8.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	14.52
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	71.47	10.59
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	88.69	7.76
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	94.29	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	84.40	11.97
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	64.96	10.83
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	77.52	7.75
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	61.18	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	83.12	12.22
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	59.61	5.04
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	78.76	5.63
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	78.48	7.39
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	113.76	13.22
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	65.30	9.98
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	82.86	7.53
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	58.44	7.62
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	32.86
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	58.67	7.01
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	67.44	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	63.22
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	76.40	10.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	53.09	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	112.35	14.20
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	54.44	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	66.01	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	54.94	9.74
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	37.62	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	87.53	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	65.39	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	49.50	11.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	10.45
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	71.47	6.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	37.41	5.54
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	42.74	11.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	49.70	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	57.48	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	69.79	6.34
Keratinocyte - epidermal, donor1	11272-116H3	138.07	71.81
Keratinocyte - epidermal, donor2	11349-117G8	63.25	15.23
Keratinocyte - epidermal, donor3	11421-118F8	259.07	88.60
Keratinocyte - oral, donor1	11251-116E9	197.75	39.73
Keratocytes, donor1	11527-119I6	36.79	3.44
Keratocytes, donor2	11607-120I5	31.64	4.69
Keratocytes, donor3	11688-122I5	82.20	7.90
Krukenberg tumor cell line:HSKTC	10687-109F3	61.54	15.39
Lens Epithelial Cells, donor1	11529-119I8	147.79	24.81
Lens Epithelial Cells, donor2	11609-120I7	150.97	40.37
Lens Epithelial Cells, donor3	11690-122I7	98.79	45.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	65.45	18.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	49.95	13.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	64.07	20.46
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	62.91	11.83
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	42.23	12.29
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	40.97	11.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	57.04	16.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	32.36	8.34
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	37.02	11.68
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	54.98	17.01
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	55.45	13.38
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	22.03	7.22
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	59.58	19.51
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	51.52	15.27
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	42.03	12.77
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	59.44	13.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	31.49	9.04
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	37.88	11.71
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	58.25	16.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	31.04	7.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	23.65	6.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	68.86	10.18
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	54.94	16.70
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	49.65	18.17
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	59.62	10.89
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	58.42	17.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	41.95	12.48
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	58.47	17.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	50.61	14.86
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	33.19	9.44
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	46.03	14.54
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	42.34	11.25
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	32.96	11.03
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	51.83	19.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	51.39	13.84
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	34.24	10.31
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	65.61	14.15
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	62.39	17.65
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	59.91	19.18
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	53.33	16.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	35.87	10.18
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	22.41	6.54
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	54.43	16.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	46.39	13.39
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	22.84	5.65
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	58.41	17.08
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	26.89	7.43
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	36.40	8.06
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	74.78	27.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	77.48	19.95
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	51.21	22.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	57.97	16.93
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	59.08	17.58
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	45.76	15.88
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	49.98	16.49
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	57.09	13.08
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	61.07	20.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	83.76	26.47
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	97.69	28.81
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	67.34	24.66
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	61.11	23.62
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	80.10	30.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	74.63	20.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	70.30	27.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	100.85	31.22
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	92.96	28.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	64.42	33.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	66.05	22.02
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	80.38	36.23
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	94.17	35.59
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	70.06	21.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	79.83	25.84
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	89.98	34.97
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	83.54	33.75
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	63.27	20.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	67.12	24.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	73.68	25.33
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	61.02	17.27
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	58.31	20.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	55.79	22.97
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	55.58	20.33
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	62.48	24.42
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	67.22	21.66
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	68.00	20.07
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	75.38	27.14
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	65.08	29.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	59.97	25.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	63.35	27.75
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	53.32	23.46
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	53.28	18.90
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	66.02	18.79
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	54.54	18.85
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	55.19	21.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	74.43	22.10
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	59.23	17.98
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	57.62	17.61
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	49.43	18.17
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	59.79	19.16
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	66.10	26.64
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	45.16	18.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	56.32	16.59
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	56.33	17.12
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	17.21
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	57.89	19.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	54.74	18.77
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	65.97	18.47
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	55.53	19.72
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	68.26	28.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	71.56	21.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	63.15	19.43
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	66.34	21.21
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	58.74	22.79
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	72.57	18.26
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	67.58	25.84
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	57.12	26.13
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	51.19	20.75
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	66.88	24.70
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	68.68	23.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	49.58	22.98
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	61.80	24.08
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	72.50	22.39
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	61.49	19.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	48.85	20.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	57.30	29.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	53.91	28.37
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	54.50	13.73
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	60.29	18.79
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	45.93	25.47
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	49.72	25.09
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	62.22	20.74
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	55.60	26.20
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	60.61	29.50
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	55.07	17.44
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	61.35	16.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	58.13	27.92
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	61.35	14.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	68.94	30.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	49.00	19.15
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	70.97	24.96
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	74.27	32.49
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	41.57	27.02
Macrophage - monocyte derived, donor1	11232-116C8	50.83	14.81
Macrophage - monocyte derived, donor2	11313-117C8	41.47	23.49
Macrophage - monocyte derived, donor3	11389-118C3	48.76	15.73
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	141.25	90.80
Mallassez-derived cells, donor2	11929-125I3	141.66	61.32
Mallassez-derived cells, donor3	11930-125I4	178.60	95.21
Mammary Epithelial Cell, donor1	11273-116H4	146.77	47.93
Mammary Epithelial Cell, donor2	11350-117G9	202.11	37.64
Mammary Epithelial Cell, donor3	11422-118F9	72.83	23.70
Mast cell - stimulated, donor1	11487-119E2	143.72	61.69
Mast cell, donor1	11563-120D6	117.22	46.93
Mast cell, donor2	11565-120D8	62.41	16.34
Mast cell, donor3	11566-120D9	61.23	9.91
Mast cell, donor4	11567-120E1	45.39	10.99
Mast cell, expanded and stimulated, donor5	11940-126A5	73.63	13.86
Mast cell, expanded and stimulated, donor8	11942-126A7	70.04	40.86
Mast cell, expanded, donor5	11939-126A4	92.24	15.60
Mast cell, expanded, donor8	11941-126A6	95.73	32.97
Melanocyte - dark, donor1	11502-119F8	100.09	30.94
Melanocyte - dark, donor2	11582-120F7	67.14	22.15
Melanocyte - dark, donor3	11663-122F7	143.07	59.62
Melanocyte - light, donor1	11274-116H5	43.72	9.64
Melanocyte - light, donor2	11351-117H1	27.30	8.87
Melanocyte - light, donor3	11423-118G1	32.09	8.67
Melanocyte, donor1 (MC+1)	12641-134G4	127.97	40.92
Melanocyte, donor2 (MC+2)	12739-135I3	98.43	45.18
Melanocyte, donor3 (MC+3)	12837-137B2	77.95	38.57
Meningeal Cells, donor1	11493-119E8	106.44	21.46
Meningeal Cells, donor2	11573-120E7	91.11	28.61
Meningeal Cells, donor3	11654-122E7	228.29	50.78
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	182.79	56.18
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	56.96	23.55
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	150.70	25.83
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	68.40	21.18
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	65.34	14.07
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	49.66	17.14
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	42.37	9.50
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	34.17	12.89
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	131.72	30.47
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	12.64	4.83
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	128.68	37.50
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.76	5.64
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	31.38	10.25
Mesenchymal stem cells - adipose, donor0	11217-116B2	178.99	37.93
Mesenchymal stem cells - hepatic, donor0	11218-116B3	115.08	30.65
Mesenchymal stem cells - umbilical, donor0	11214-116A8	150.94	30.48
Mesothelial Cells, donor1	11247-116E5	73.98	27.84
Mesothelial Cells, donor2	12156-128G5	67.56	38.04
Mesothelial Cells, donor3	11402-118D7	49.21	26.02
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	17.55
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	58.12	29.80
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	36.81	15.90
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	57.65	30.37
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	34.02	16.80
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	51.05	28.03
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	35.38	15.83
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	51.82	25.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.13	16.23
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	46.90	15.93
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	42.93	23.94
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	6.58
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	43.72	24.83
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.97	9.21
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	39.94	16.10
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	8.38
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	40.65	25.84
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	32.09	16.40
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	8.85
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	44.90	23.02
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	31.76	14.09
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	32.82	14.06
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	48.70	16.73
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	23.56	12.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	38.77	14.46
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.18	7.60
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	6.63
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	35.60	18.21
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	23.53	15.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	6.54
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	38.44	13.46
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	29.22	17.21
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	15.08	5.48
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	43.55	22.53
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	53.89
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	42.92	19.27
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	9.93
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	6.40	3.84
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	46.61	19.09
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	7.65
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	36.58	17.44
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	15.32	4.81
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.59	3.20
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	36.75	12.06
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	21.61	5.82
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.74	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	32.88	11.76
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	22.96	13.36
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	32.32	17.55
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	20.49	10.81
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	22.66	7.74
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	33.43	16.07
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	22.31	7.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	2.54
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	26.69	9.61
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	30.53	14.07
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	26.41	7.77
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	34.72	13.70
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.99	12.16
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	16.31	5.69
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	42.62	16.19
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	31.22	8.85
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.99	6.52
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	36.17	8.82
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	36.91	11.24
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	32.56	15.66
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	38.41	10.42
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	79.10	15.07
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	65.94	19.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	63.09	26.29
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	72.58	18.94
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	72.16	17.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	66.12	18.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	46.94	21.03
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	46.34	18.38
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	54.85	14.70
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	41.99	13.26
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	53.50	13.56
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	45.11	10.89
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	86.58	16.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	42.50	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	43.43	15.15
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	46.80	14.34
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	80.35	25.88
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	91.55	29.25
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	110.14	29.15
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	49.84	10.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	39.97
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	45.67	55.46
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	37.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	98.02	31.45
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	60.10	30.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	54.07	21.36
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	70.12	21.70
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	144.89	36.89
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	98.94	41.49
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	40.12	9.52
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	187.44	38.59
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	48.97	28.88
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	109.25	34.17
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	50.53	22.16
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	60.34	31.12
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	267.23	111.35
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	44.67	26.80
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	71.73	28.69
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	58.71	27.88
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	49.32	17.31
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	60.14	22.24
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	47.21	32.89
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	35.42	15.61
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	86.31	29.86
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	49.93	24.88
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	56.27	26.46
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	49.23	33.05
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	57.00	18.39
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	50.13	25.06
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	137.61	45.87
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	242.73	42.98
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	58.15	25.17
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	60.12	23.29
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	59.58	21.36
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	65.68	24.90
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	279.86	108.33
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	57.98	18.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	39.23	22.09
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	61.90	23.81
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	46.43	19.50
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	88.92	24.59
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	43.02	21.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	32.68	10.89
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	59.70	18.09
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	48.50	29.98
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	64.49	26.59
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	53.57	19.84
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	40.20	18.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	76.82	21.47
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	61.22	26.96
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	50.15	34.56
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	178.83	71.53
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	50.60	18.29
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	54.76	24.23
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	40.86	11.20
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	61.71	21.36
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	103.16	36.28
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	242.78	40.46
Myoblast, donor1	11241-116D8	88.57	51.55
Myoblast, donor2	11322-117D8	81.32	23.59
Myoblast, donor3	11398-118D3	79.71	23.88
NK T cell leukemia cell line:KHYG-1	10777-110G3	140.83	24.66
Natural Killer Cells, donor1	11230-116C6	42.44	20.60
Natural Killer Cells, donor2	11311-117C6	43.73	13.27
Natural Killer Cells, donor3	11387-118C1	39.02	15.83
Neural stem cells, donor1	11275-116H6	148.44	56.98
Neural stem cells, donor2	11352-117H2	102.06	36.59
Neurons, donor1	11494-119E9	106.96	37.55
Neurons, donor2	11574-120E8	89.39	38.97
Neurons, donor3	11655-122E8	112.64	59.20
Neutrophils, donor1	11233-116C9	6.50	0.93
Neutrophils, donor2	11314-117C9	5.80	0.00
Neutrophils, donor3	11390-118C4	4.28	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	91.19	29.57
Nucleus Pulposus Cell, donor2	11409-118E5	53.72	29.63
Nucleus Pulposus Cell, donor3	11462-119B4	83.03	22.66
Olfactory epithelial cells, donor1	11933-125I7	63.87	18.72
Olfactory epithelial cells, donor2	11934-125I8	81.20	23.59
Olfactory epithelial cells, donor3	11935-125I9	63.00	22.47
Olfactory epithelial cells, donor4	11936-126A1	92.72	26.39
Oligodendrocyte - precursors, donor1	11496-119F2	179.94	47.54
Osteoblast - differentiated, donor1	11276-116H7	58.28	16.59
Osteoblast - differentiated, donor2	11353-117H3	32.01	16.00
Osteoblast - differentiated, donor3	11425-118G3	36.00	22.35
Osteoblast, donor1	11277-116H8	56.48	11.73
Osteoblast, donor2	11354-117H4	122.91	29.50
Osteoblast, donor3	11426-118G4	83.71	23.64
Pancreatic stromal cells, donor1	11249-116E7	117.59	29.15
Pericytes, donor1	11491-119E6	13.80	5.56
Pericytes, donor2	11571-120E5	14.49	5.43
Pericytes, donor3	11652-122E5	34.59	9.16
Perineurial Cells, donor1	11499-119F5	193.83	45.10
Perineurial Cells, donor2	11579-120F4	84.19	35.70
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	48.45	19.76
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	28.40	7.10
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	27.44	9.58
Placental Epithelial Cells, donor1	11278-116H9	36.11	9.09
Placental Epithelial Cells, donor2	11355-117H5	45.46	6.65
Placental Epithelial Cells, donor3	11427-118G5	39.66	10.80
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	53.48	24.37
Preadipocyte - breast, donor1	11467-119B9	65.28	26.83
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	42.55	19.97
Preadipocyte - breast, donor2	11328-117E5	57.86	23.87
Preadipocyte - omental, donor1	11468-119C1	70.33	36.34
Preadipocyte - omental, donor2	11329-117E6	75.95	26.62
Preadipocyte - omental, donor3	11403-118D8	64.32	29.37
Preadipocyte - perirenal, donor1	11469-119C2	48.23	17.72
Preadipocyte - subcutaneous, donor1	11279-116I1	36.55	15.05
Preadipocyte - subcutaneous, donor2	11356-117H6	141.66	37.19
Preadipocyte - subcutaneous, donor3	11428-118G6	103.19	30.99
Preadipocyte - visceral, donor1	11280-116I2	132.92	35.77
Preadipocyte - visceral, donor2	11357-117H7	71.33	17.95
Preadipocyte - visceral, donor3	11429-118G7	96.76	30.41
Prostate Epithelial Cells (polarized), donor1	11253-116F2	128.38	61.70
Prostate Epithelial Cells, donor2	11331-117E8	83.82	40.49
Prostate Epithelial Cells, donor3	11404-118D9	64.12	8.82
Prostate Stromal Cells, donor1	11254-116F3	105.36	20.50
Prostate Stromal Cells, donor2	11332-117E9	102.56	17.75
Prostate Stromal Cells, donor3	11405-118E1	54.85	18.56
Renal Cortical Epithelial Cells, donor1	11516-119H4	22.26	7.66
Renal Cortical Epithelial Cells, donor2	11596-120H3	159.97	39.16
Renal Epithelial Cells, donor1	11517-119H5	14.20	2.03
Renal Epithelial Cells, donor2	11597-120H4	15.65	4.27
Renal Epithelial Cells, donor3	11678-122H4	155.83	31.34
Renal Glomerular Endothelial Cells, donor1	11514-119H2	15.66	4.09
Renal Glomerular Endothelial Cells, donor2	11594-120H1	54.85	16.98
Renal Glomerular Endothelial Cells, donor3	11675-122H1	103.68	27.75
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	3.99
Renal Mesangial Cells, donor1	11518-119H6	22.23	7.04
Renal Mesangial Cells, donor2	11598-120H5	30.72	5.02
Renal Mesangial Cells, donor3	11679-122H5	9.15	2.77
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	71.67	17.45
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	33.74	7.17
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	30.47	8.68
Retinal Pigment Epithelial Cells, donor0	11215-116A9	216.24	42.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	55.71	16.77
Retinal Pigment Epithelial Cells, donor2	11608-120I6	34.99	8.23
Retinal Pigment Epithelial Cells, donor3	11689-122I6	116.17	30.61
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	93.14	36.22
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	213.52	34.84
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	232.26	37.98
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	192.00	31.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	275.13	48.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	209.63	39.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	306.17	57.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	301.67	52.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	226.80	38.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	240.38	51.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	183.46	36.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	213.45	39.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	253.38	55.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	215.33	40.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	210.12	38.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	228.35	46.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	183.91	37.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	194.80	36.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	306.66	54.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	190.57	38.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	202.47	40.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	241.56	56.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	207.93	36.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	205.18	35.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	204.05	43.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	190.54	40.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	193.88	34.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	244.46	50.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	221.96	47.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	206.75	42.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	247.64	50.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	203.21	38.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	224.09	38.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	217.24	48.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	217.49	45.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	171.49	39.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	199.93	45.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	197.38	42.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	180.51	40.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	207.67	49.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	171.62	39.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	210.25	56.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	187.39	49.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	205.19	33.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	216.67	53.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	201.54	51.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	181.57	38.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	204.38	48.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	131.76	29.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	203.04	38.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	246.13	54.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	215.99	39.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	179.94	50.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	157.65	35.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	239.33	38.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	201.55	33.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	189.75	41.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	207.94	47.48
Schwann Cells, donor1	11498-119F4	29.72	7.33
Schwann Cells, donor2	11578-120F3	166.72	17.01
Schwann Cells, donor3	11659-122F3	120.71	35.27
Sebocyte, donor1	11220-116B5	155.02	75.59
Sebocyte, donor2	11301-117B5	134.65	65.72
Sebocyte, donor3	11378-118B1	57.92	24.32
Sertoli Cells, donor1	11255-116F4	119.28	29.82
Sertoli Cells, donor2	11333-117F1	56.49	28.24
Skeletal Muscle Cells, donor1	11281-116I3	72.32	17.77
Skeletal Muscle Cells, donor2	11358-117H8	18.79	7.23
Skeletal Muscle Cells, donor3	11430-118G8	75.24	11.70
Skeletal Muscle Cells, donor4	11451-119A2	164.63	44.14
Skeletal Muscle Cells, donor5	11455-119A6	170.20	46.38
Skeletal Muscle Cells, donor6	11459-119B1	249.63	56.33
Skeletal Muscle Satellite Cells, donor1	11240-116D7	150.45	60.36
Skeletal Muscle Satellite Cells, donor2	11321-117D7	138.84	37.10
Skeletal Muscle Satellite Cells, donor3	11397-118D2	203.88	55.06
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	104.73	36.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	58.62	10.13
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	42.11	17.89
Skin - palm, donor1	10286-104F7	53.72	10.74
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	43.97	16.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	62.16	17.99
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	59.33	19.73
Small Airway Epithelial Cells, donor1	11256-116F5	85.91	23.21
Small Airway Epithelial Cells, donor2	11334-117F2	41.35	14.07
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	50.75	17.55
Small Airway Epithelial Cells, donor3	11406-118E2	45.72	10.49
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	89.18	27.77
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	37.80	11.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	58.19	14.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	40.44	5.97
Smooth Muscle Cells - Aortic, donor2	11360-117I1	44.10	11.42
Smooth Muscle Cells - Aortic, donor3	11432-118H1	62.58	19.31
Smooth Muscle Cells - Bladder, donor1	11519-119H7	78.06	10.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	56.03	16.90
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	70.04	23.27
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	78.99	27.14
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	122.75	51.44
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	111.93	52.86
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	79.72	37.73
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	20.17	5.04
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	68.50	22.53
Smooth Muscle Cells - Carotid, donor1	11285-116I7	50.77	11.62
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	43.39	5.25
Smooth Muscle Cells - Colonic, donor1	11239-116D6	107.21	25.37
Smooth Muscle Cells - Colonic, donor2	11320-117D6	114.72	33.15
Smooth Muscle Cells - Colonic, donor3	11396-118D1	119.86	33.80
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	43.46	10.05
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	40.96	22.64
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	59.77	13.45
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	26.29	2.39
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	116.30	31.25
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	61.69	25.16
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	51.20	22.76
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	50.72	7.25
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	244.79	49.54
Smooth Muscle Cells - Prostate, donor1	11257-116F6	121.97	26.63
Smooth Muscle Cells - Prostate, donor2	11335-117F3	65.74	20.16
Smooth Muscle Cells - Prostate, donor3	11465-119B7	50.48	25.87
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	87.15	21.56
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	29.26	8.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	41.35	7.75
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	50.23	8.84
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	47.46	19.69
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	52.34	20.06
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	23.30	7.37
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	164.03	31.66
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	85.02	27.10
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	45.48	11.37
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	56.86	14.28
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	55.85	11.66
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	187.54	48.07
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	131.38	34.94
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	16.19	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	51.62	11.99
Smooth Muscle Cells - Uterine, donor1	11258-116F7	92.80	27.84
Smooth Muscle Cells - Uterine, donor3	11466-119B8	130.20	26.62
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	53.64	16.13
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	48.92	19.83
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	72.53	13.02
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	84.44	24.79
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	66.43	15.90
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	113.83	27.96
Smooth muscle cells - airway, control, donor1	11966-126D4	58.92	15.49
Smooth muscle cells - airway, control, donor2	11967-126D5	63.89	9.18
Smooth muscle cells - airway, control, donor3	11968-126D6	70.64	17.14
Smooth muscle cells - airway, control, donor4	11969-126D7	66.46	17.88
Synoviocyte, donor1	11291-117A4	80.79	27.10
Synoviocyte, donor2	11368-117I9	56.49	25.31
Synoviocyte, donor3	11440-118H9	58.53	20.33
Trabecular Meshwork Cells, donor1	11532-120A2	46.45	7.50
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	24.78	7.87
Tracheal Epithelial Cells, donor1	11292-117A5	75.48	14.70
Tracheal Epithelial Cells, donor2	11369-118A1	39.04	7.73
Tracheal Epithelial Cells, donor3	11441-118I1	46.96	8.59
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	84.89	36.91
Urethra, donor2	10319-105A4	37.77	46.76
Urothelial Cells, donor1	11520-119H8	34.80	8.77
Urothelial Cells, donor2	11600-120H7	30.84	5.21
Urothelial Cells, donor3	11681-122H7	19.71	3.90
Urothelial cells, donor0	11216-116B1	123.04	19.61
Whole blood (ribopure), donor090309, donation1	12179-129A1	51.61	20.47
Whole blood (ribopure), donor090309, donation2	12180-129A2	22.87	21.44
Whole blood (ribopure), donor090309, donation3	12181-129A3	18.48	6.85
Whole blood (ribopure), donor090325, donation1	12176-128I7	34.09	21.35
Whole blood (ribopure), donor090325, donation2	12177-128I8	34.86	15.11
Whole blood (ribopure), donor090612, donation1	12182-129A4	22.91	11.45
Whole blood (ribopure), donor090612, donation2	12183-129A5	35.79	14.68
Whole blood (ribopure), donor090612, donation3	12184-129A6	22.82	6.39
Wilms' tumor cell line:G-401	10809-111A8	193.68	68.96
Wilms' tumor cell line:HFWT	10597-108E3	67.76	13.20
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	214.24	38.83
achilles tendon, donor2	10292-104G4	39.26	12.40
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	84.65	28.56
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	232.17	48.99
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	157.64	42.50
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	187.21	67.76
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	260.85	60.43
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	171.30	58.79
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	68.87	26.95
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	206.22	46.71
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	117.20	50.64
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	133.96	55.91
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	131.56	22.45
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	156.02	50.71
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	359.73	130.83
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	208.42	37.80
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	111.34	16.95
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	105.50	61.35
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	126.67	15.22
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	509.23	834.29
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	521.86	782.58
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	434.01	551.08
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	552.18	817.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	300.70	108.25
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	52.37	12.01
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	65.04	26.01
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	178.91	44.45
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	69.78	28.78
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	50.61	18.74
adenocarcinoma cell line:IM95m	10796-110I4	140.36	42.63
adipose tissue, adult, pool1	10010-101C1	51.03	20.01
adipose, donor1	10184-103D4	448.02	80.92
adipose, donor2	10185-103D5	113.95	23.52
adipose, donor3	10186-103D6	150.30	40.30
adipose, donor4	10187-103D7	212.35	65.01
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	138.41	31.09
adrenal gland, adult, pool1	10081-102A9	43.65	32.74
adult T-cell leukemia cell line:ATN-1	10421-106C7	100.99	11.21
alveolar cell carcinoma cell line:SW 1573	10708-109H6	249.40	35.73
amniotic membrane cells, donor1	12235-129G3	67.93	25.74
amniotic membrane cells, donor2	12236-129G4	75.74	19.27
amniotic membrane cells, donor3	12237-129G5	65.99	23.57
amygdala - adult, donor10196	10167-103B5	81.82	66.40
amygdala, adult, donor10252	10151-102I7	63.47	60.02
amygdala, newborn, donor10223	10360-105E9	58.74	51.97
anaplastic carcinoma cell line:8305C	10428-106D5	92.57	15.92
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	239.60	78.76
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	207.77	55.78
aorta, adult, pool1	10052-101G7	49.43	19.22
appendix, adult	10189-103D9	71.03	19.79
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	121.41	26.83
artery, adult	10190-103E1	69.29	52.99
astrocytoma cell line:TM-31	10425-106D2	238.45	42.45
b cell line:RPMI1788	10427-106D4	134.13	21.41
basal cell carcinoma cell line:TE 354.T	10702-109G9	121.80	33.02
bile duct carcinoma cell line:HuCCT1	10432-106D9	117.99	21.43
bile duct carcinoma cell line:TFK-1	10496-107C1	46.03	6.03
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	62.08	23.49
bladder, adult, pool1	10011-101C2	77.68	16.30
blood, adult, pool1	10053-101G8	24.36	13.29
bone marrow stromal cell line:StromaNKtert	10686-109F2	77.07	21.41
bone marrow, adult	10192-103E3	68.83	18.90
brain, adult, donor1	10084-102B3	66.63	36.90
brain, adult, pool1	10012-101C3	86.08	55.57
brain, fetal, pool1	10085-102B4	34.73	37.40
breast carcinoma cell line:MCF7	10482-107A5	94.15	35.35
breast carcinoma cell line:MDA-MB-453	10419-106C5	115.46	40.94
breast, adult, donor1	10080-102A8	42.30	33.46
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	85.12	20.20
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	167.29	46.38
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	217.10	45.58
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	63.43	13.31
carcinoid cell line:NCI-H1770	10703-109H1	255.30	28.68
carcinoid cell line:NCI-H727	10735-110B6	53.92	14.00
carcinoid cell line:SK-PN-DW	10719-109I8	361.89	54.51
carcinosarcoma cell line:JHUCS-1	10642-109A3	177.54	31.94
caudate nucleus - adult, donor10196	10177-103C6	94.41	54.11
caudate nucleus, adult, donor10252	10164-103B2	69.78	79.65
caudate nucleus, adult, donor10258	10379-105H1	88.64	103.16
caudate nucleus, newborn, donor10223	10354-105E3	70.32	50.17
cerebellum - adult, donor10196	10173-103C2	104.88	52.44
cerebellum, adult, donor10252	10166-103B4	75.58	37.79
cerebellum, adult, pool1	10083-102B2	74.16	32.42
cerebellum, newborn, donor10223	10357-105E6	78.05	50.65
cerebral meninges, adult	10188-103D8	85.73	49.17
cerebrospinal fluid, donor2	10294-104G6	43.12	43.12
cervical cancer cell line:D98-AH2	10552-107I3	184.47	43.57
cervical cancer cell line:ME-180	10553-107I4	147.16	35.13
cervix, adult, pool1	10013-101C4	92.18	25.83
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	143.52	45.98
chondrosarcoma cell line:SW 1353	10700-109G7	61.39	13.06
choriocarcinoma cell line:BeWo	10423-106C9	229.29	61.77
choriocarcinoma cell line:SCH	10785-110H2	174.22	89.70
choriocarcinoma cell line:T3M-3	10618-108G6	49.81	10.20
chorionic membrane cells, donor1	12238-129G6	92.88	43.59
chorionic membrane cells, donor2	12239-129G7	99.93	32.91
chorionic membrane cells, donor3	12240-129G8	145.61	84.07
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	111.08	20.20
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	211.88	86.64
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	177.19	56.81
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	221.36	23.88
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	229.54	27.09
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	228.86	29.32
chronic myelogenous leukemia cell line:K562	10454-106G4	481.73	87.45
chronic myelogenous leukemia cell line:KU812	10409-106B4	268.44	70.63
clear cell carcinoma cell line:JHOC-5	10638-108I8	189.27	48.69
clear cell carcinoma cell line:TEN	10636-108I6	142.45	37.65
colon carcinoma cell line:CACO-2	10513-107D9	212.15	123.74
colon carcinoma cell line:COLO-320	10420-106C6	308.25	47.13
colon, adult, donor1	10082-102B1	80.92	34.51
colon, adult, pool1	10014-101C5	102.70	66.86
colon, fetal, donor1	10070-101I7	45.11	19.78
common myeloid progenitor CMP, donor1	12130-128D6	18.33	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	50.07
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	84.14	30.17
cord blood derived cell line:COBL-a 24h infection	10453-106G3	116.37	43.62
cord blood derived cell line:COBL-a untreated	10449-106F8	125.08	51.75
corpus callosum, adult, pool1	10042-101F6	59.70	39.03
cruciate ligament, donor2	10295-104G7	39.71	15.40
diaphragm, fetal, donor1	10069-101I6	59.39	45.75
diencephalon, adult	10193-103E4	54.96	46.32
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	210.09	38.35
ductal cell carcinoma cell line:KLM-1	10438-106E6	136.17	14.87
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	214.48	73.90
ductus deferens, adult	10196-103E7	55.32	30.40
duodenum, fetal, donor1, tech_rep1	10071-101I8	69.13	38.89
duodenum, fetal, donor1, tech_rep2	10071-101I8	90.48	22.07
dura mater, adult, donor1	10041-101F5	78.21	21.47
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	202.09	77.06
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	422.86	128.25
embryonic pancreas cell line:1B2C6	10604-108F1	107.29	14.18
embryonic pancreas cell line:1C3D3	10605-108F2	121.99	7.57
embryonic pancreas cell line:1C3IKEI	10606-108F3	93.55	12.04
embryonic pancreas cell line:2C6	10603-108E9	123.47	11.82
endometrial carcinoma cell line:OMC-2	10497-107C2	202.46	45.59
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	112.55	23.74
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	91.99	30.88
epidermoid carcinoma cell line:A431	10426-106D3	151.73	38.35
epidermoid carcinoma cell line:Ca Ski	10431-106D8	271.00	50.37
epididymis, adult	10197-103E8	72.42	30.56
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	130.93	29.63
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	90.45	14.55
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	188.06	48.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	158.06	37.99
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	184.40	53.44
esophagus, adult, pool1	10015-101C6	64.87	25.48
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	173.20	35.94
eye - muscle inferior rectus, donor1	10272-104E2	74.85	31.39
eye - muscle lateral, donor2	10298-104H1	65.23	23.15
eye - muscle medial, donor2	10299-104H2	52.09	29.76
eye - muscle superior, donor2	10297-104G9	41.27	30.96
eye - vitreous humor, donor1	10268-104D7	87.44	33.52
eye, fetal, donor1	10054-101G9	89.24	32.03
fibrosarcoma cell line:HT-1080	10758-110E2	172.08	32.44
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	264.01	59.83
frontal lobe, adult, pool1	10040-101F4	87.82	71.87
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	214.98	50.44
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	164.31	16.55
gall bladder, adult	10198-103E9	47.32	12.80
gamma delta positive T cells, donor1	11937-126A2	64.42	22.01
gamma delta positive T cells, donor2	11938-126A3	52.29	26.14
gastric adenocarcinoma cell line:MKN1	10614-108G2	108.35	24.50
gastric adenocarcinoma cell line:MKN45	10612-108F9	219.72	24.37
gastric cancer cell line:AZ521	10549-107H9	153.46	56.73
gastric cancer cell line:GSS	10560-108A2	311.18	41.19
gastrointestinal carcinoma cell line:ECC12	10615-108G3	69.22	26.04
giant cell carcinoma cell line:LU65	10487-107B1	300.39	21.80
giant cell carcinoma cell line:Lu99B	10433-106E1	299.37	60.18
glassy cell carcinoma cell line:HOKUG	10688-109F4	85.55	25.44
glioblastoma cell line:A172, tech_rep1	10444-106F3	101.33	30.82
glioblastoma cell line:A172, tech_rep2	10444-106F3	97.32	32.30
glioblastoma cell line:T98G	10485-107A8	165.89	27.70
glioma cell line:GI-1	10413-106B8	141.75	48.32
globus pallidus - adult, donor10196	10175-103C4	72.16	56.86
globus pallidus, adult, donor10252	10161-103A8	61.27	53.46
globus pallidus, adult, donor10258	10367-105F7	65.72	45.18
globus pallidus, newborn, donor10223	10364-105F4	68.75	50.09
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	57.49	31.36
granulosa cell tumor cell line:KGN	10624-108H3	75.52	30.08
hIPS +CCl2, biol_rep1	14383-156B9	282.36	58.31
hIPS +CCl2, biol_rep2	14384-156C1	247.38	45.73
hIPS +CCl2, biol_rep3	14385-156C2	318.83	60.54
hIPS, biol_rep1	14380-156B6	403.88	37.37
hIPS, biol_rep2	14381-156B7	275.03	52.81
hIPS, biol_rep3	14382-156B8	128.00	62.90
hairy cell leukemia cell line:Mo	10712-109I1	168.96	84.48
heart - mitral valve, adult	10205-103F7	60.39	32.59
heart - pulmonic valve, adult	10206-103F8	53.60	20.66
heart - tricuspid valve, adult	10207-103F9	44.13	14.99
heart, adult, diseased post-infarction, donor1	10050-101G5	84.07	24.49
heart, adult, diseased, donor1	10051-101G6	70.26	29.81
heart, adult, pool1	10016-101C7	58.41	26.45
heart, fetal, pool1	10046-101G1	96.62	42.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	61.40	22.52
hepatoblastoma cell line:HuH-6	10633-108I3	65.40	20.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	143.31	64.64
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	158.15	69.67
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	150.57	58.61
hepatoma cell line:Li-7	10484-107A7	189.07	32.25
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	178.89	27.84
hippocampus - adult, donor10196	10169-103B7	73.81	73.81
hippocampus, adult, donor10252	10153-102I9	58.98	47.96
hippocampus, adult, donor10258	10374-105G5	103.57	47.80
hippocampus, newborn, donor10223	10363-105F3	68.73	70.14
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	408.32	108.03
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	243.68	62.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	243.99	63.47
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	244.15	49.62
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	209.93	42.35
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	238.02	40.62
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	196.48	44.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	193.89	36.41
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	183.10	50.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	198.43	62.51
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	176.31	61.39
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	212.09	53.86
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	249.12	61.19
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	251.54	60.43
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	399.72	92.51
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	220.50	42.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	228.07	30.96
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	245.38	44.98
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	122.08	15.07
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	134.14	15.46
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	145.03	16.60
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	120.68	39.85
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	124.25	37.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	113.89	29.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	253.65	74.64
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	230.80	75.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	358.50	104.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	221.11	47.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	205.56	52.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	202.76	50.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	166.00	26.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	148.77	45.16
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	150.84	39.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	150.58	49.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	168.10	57.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	180.13	68.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	235.23	68.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	258.93	76.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	268.78	75.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	226.16	42.18
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1252.50	208.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	294.87	59.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	211.80	35.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	183.11	38.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	168.68	30.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	229.13	36.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	266.11	67.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	196.93	53.07
immature langerhans cells, donor1	11904-125F5	42.62	12.59
immature langerhans cells, donor2	11905-125F6	38.81	26.14
insula, adult, pool1	10039-101F3	87.35	66.15
keratoacanthoma cell line:HKA-1	10791-110H8	148.92	33.17
kidney, adult, pool1	10017-101C8	73.19	28.94
kidney, fetal, pool1	10045-101F9	55.95	23.41
large cell lung carcinoma cell line:IA-LM	10509-107D5	265.44	97.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	56.40	14.65
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	101.11	19.08
left atrium, adult, donor1	10079-102A7	63.20	42.50
left ventricle, adult, donor1	10078-102A6	94.05	40.45
leiomyoblastoma cell line:G-402	10721-110A1	143.10	30.10
leiomyoma cell line:10964C	10569-108B2	62.15	16.88
leiomyoma cell line:15242A	10570-108B3	55.98	9.78
leiomyoma cell line:15425	10571-108B4	80.37	22.10
leiomyosarcoma cell line:Hs 5.T	10722-110A2	95.24	25.40
lens epithelial cell line:SRA 01/04	10647-109A8	103.51	38.69
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	164.10	92.32
liposarcoma cell line:KMLS-1	10782-110G8	68.58	21.09
liposarcoma cell line:SW 872	10726-110A6	115.87	31.43
liver, adult, pool1	10018-101C9	97.07	32.57
liver, fetal, pool1	10086-102B5	94.07	60.21
locus coeruleus - adult, donor10196	10182-103D2	62.12	61.10
locus coeruleus, adult, donor10252	10165-103B3	62.19	62.38
locus coeruleus, adult, donor10258	10375-105G6	74.48	77.59
locus coeruleus, newborn, donor10223	10362-105F2	78.24	51.74
lung adenocarcinoma cell line:A549	10499-107C4	38.20	10.10
lung adenocarcinoma cell line:PC-14	10408-106B3	77.90	29.64
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	174.52	33.35
lung, adult, pool1	10019-101D1	89.66	42.76
lung, fetal, donor1	10068-101I5	140.71	49.38
lung, right lower lobe, adult, donor1	10075-102A3	74.69	35.28
lymph node, adult, donor1	10077-102A5	54.44	34.08
lymphangiectasia cell line:DS-1	10727-110A7	67.95	17.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	107.46	21.43
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	112.13	42.47
mature adipocyte, donor1	12231-129F8	67.04	22.20
mature adipocyte, donor2	12232-129F9	81.77	27.39
mature adipocyte, donor3	12233-129G1	67.80	15.41
mature adipocyte, donor4	12234-129G2	83.97	35.80
maxillary sinus tumor cell line:HSQ-89	10414-106B9	128.90	22.40
medial frontal gyrus - adult, donor10196	10170-103B8	97.01	72.19
medial frontal gyrus, adult, donor10252	10150-102I6	72.46	66.02
medial frontal gyrus, adult, donor10258	10368-105F8	98.48	73.07
medial frontal gyrus, newborn, donor10223	10352-105E1	96.39	83.17
medial temporal gyrus - adult, donor10196	10183-103D3	89.94	66.66
medial temporal gyrus, adult, donor10252	10156-103A3	61.55	59.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	109.80	57.79
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	172.24	114.83
medial temporal gyrus, newborn, donor10223	10353-105E2	66.76	54.20
medulla oblongata - adult, donor10196	10174-103C3	90.86	64.25
medulla oblongata, adult, donor10252	10155-103A2	69.35	55.57
medulla oblongata, adult, pool1	10038-101F2	66.53	47.34
medulla oblongata, newborn, donor10223	10361-105F1	63.19	54.85
medulloblastoma cell line:D283 Med	10838-111E1	248.42	54.47
medulloblastoma cell line:ONS-76	10759-110E3	108.82	27.63
melanoma cell line:COLO 679	10514-107E1	93.87	44.56
melanoma cell line:G-361	10465-106H6	174.01	22.26
meningioma cell line:HKBMM	10691-109F7	77.07	9.59
merkel cell carcinoma cell line:MKL-1	10843-111E6	139.22	37.01
merkel cell carcinoma cell line:MS-1	10844-111E7	108.36	31.37
mesenchymal precursor cell - adipose, donor1	11747-123G1	99.27	25.78
mesenchymal precursor cell - adipose, donor2	11748-123G2	80.53	24.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	87.38	23.60
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	73.19	26.27
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	63.74	28.50
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	72.18	34.70
mesenchymal precursor cell - cardiac, donor1	11752-123G6	59.39	23.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	66.48	18.98
mesenchymal precursor cell - cardiac, donor3	11754-123G8	75.87	23.34
mesenchymal precursor cell - cardiac, donor4	11755-123G9	89.53	22.82
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	83.65	27.88
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	58.95	21.08
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	83.30	25.88
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	75.05	17.45
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	86.36	24.50
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	60.39	18.69
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	65.17	16.24
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	49.25	18.01
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	141.39	46.15
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	74.12	24.06
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	65.74	26.17
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	76.21	23.93
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	64.96	18.60
mesenchymal stem cell line:Hu5/E18	10568-108B1	166.72	45.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	64.85	19.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	61.39	20.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	65.96	21.20
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	55.15	20.64
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	53.43	16.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	57.20	25.38
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	53.44	15.33
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	50.51	17.61
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	71.82	24.80
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	63.81	22.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	58.41	21.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	74.07	19.80
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	50.01	16.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	58.54	18.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	64.00	25.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	19.14
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	72.31	15.49
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	71.45	23.06
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	74.20	17.46
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	73.03	21.32
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	80.14	18.81
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	62.58	19.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	81.85	12.59
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	56.63	11.92
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	19.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	54.55	19.57
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	54.83	29.24
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	54.10
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	72.21	15.83
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	55.87	19.31
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	64.48	8.60
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	19.96
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	48.21	17.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	36.26	13.45
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	51.64	14.30
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	37.14	14.74
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	46.44	19.64
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	46.78	9.36
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	55.59	22.47
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	84.74	33.38
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	72.97	25.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	71.75	26.22
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	66.17	30.28
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	82.69	31.80
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	83.82	36.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	67.60	30.53
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	58.28	20.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	52.19	23.67
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	27.11
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	63.42	29.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	70.04	28.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	54.51	20.77
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	46.86	17.32
mesodermal tumor cell line:HIRS-BM	10696-109G3	68.86	26.31
mesothelioma cell line:ACC-MESO-1	10493-107B7	193.01	18.66
mesothelioma cell line:ACC-MESO-4	10494-107B8	115.84	23.17
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	38.46
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	142.31	50.14
mesothelioma cell line:Mero-25	10850-111F4	94.41	25.19
mesothelioma cell line:Mero-41	10851-111F5	158.66	19.31
mesothelioma cell line:Mero-48a	10852-111F6	91.67	31.66
mesothelioma cell line:Mero-82	10853-111F7	69.64	27.86
mesothelioma cell line:Mero-83	10854-111F8	90.39	34.21
mesothelioma cell line:Mero-84	10855-111F9	106.17	22.75
mesothelioma cell line:Mero-95	10856-111G1	61.91	23.40
mesothelioma cell line:NCI-H2052	10847-111F1	96.41	32.47
mesothelioma cell line:NCI-H226	10846-111E9	48.69	8.69
mesothelioma cell line:NCI-H2452	10848-111F2	119.58	24.60
mesothelioma cell line:NCI-H28	10845-111E8	118.07	27.48
mesothelioma cell line:No36	10857-111G2	111.89	32.29
mesothelioma cell line:ONE58	10858-111G3	236.54	64.49
migratory langerhans cells, donor1	11901-125F2	104.21	22.45
migratory langerhans cells, donor2	11902-125F3	84.99	16.00
migratory langerhans cells, donor3	11903-125F4	86.69	18.49
mixed mullerian tumor cell line:HTMMT	10689-109F5	302.65	28.73
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	193.71	35.61
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	94.22	17.51
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	105.23	49.67
myelodysplastic syndrome cell line:SKM-1	10772-110F7	259.26	42.87
myeloma cell line:PCM6	10474-106I6	80.25	23.92
myxofibrosarcoma cell line:MFH-ino	10600-108E6	75.59	38.55
myxofibrosarcoma cell line:NMFH-1	10684-109E9	89.83	16.67
nasal epithelial cells, donor1, tech_rep1	12226-129F3	78.33	9.58
nasal epithelial cells, donor1, tech_rep2	12226-129F3	89.87	10.08
nasal epithelial cells, donor2	12227-129F4	66.24	7.18
neuroblastoma cell line:CHP-134	10508-107D4	113.42	44.17
neuroblastoma cell line:NB-1	10539-107G8	136.95	76.33
neuroblastoma cell line:NBsusSR	10607-108F4	212.15	38.80
neuroblastoma cell line:NH-12	10555-107I6	162.31	41.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	92.76	42.46
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	139.06	39.60
neuroectodermal tumor cell line:TASK1	10774-110F9	188.18	52.53
neuroepithelioma cell line:SK-N-MC	10728-110A8	192.00	48.32
neurofibroma cell line:Hs 53.T	10729-110A9	64.15	18.10
neutrophil PMN, donor1	12133-128D9	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	345.85	29.93
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	122.48	25.62
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	78.23	25.97
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	80.93	23.65
nucleus accumbens, adult, pool1	10037-101F1	73.49	58.77
occipital cortex - adult, donor10196	10172-103C1	123.62	65.93
occipital cortex, adult, donor10252	10163-103B1	61.19	57.70
occipital cortex, newborn, donor10223	10355-105E4	56.05	71.70
occipital lobe, adult, donor1	10076-102A4	83.71	70.59
occipital lobe, fetal, donor1	10073-102A1	72.09	46.34
occipital pole, adult, pool1	10036-101E9	49.20	32.25
olfactory region, adult	10195-103E6	72.60	35.73
optic nerve, donor1	10277-104E7	56.03	42.02
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	93.18	33.26
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	266.94	30.36
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	47.92	9.14
oral squamous cell carcinoma cell line:SAS	10544-107H4	144.62	18.02
osteoclastoma cell line:Hs 706.T	10704-109H2	66.14	19.99
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	237.32	49.52
osteosarcoma cell line:HS-Os-1	10558-107I9	550.51	331.87
ovary, adult, pool1	10020-101D2	81.06	34.24
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	79.19	27.68
pancreas, adult, donor1	10049-101G4	65.84	18.81
pancreatic carcinoma cell line:NOR-P1	10698-109G5	139.49	44.45
papillary adenocarcinoma cell line:8505C	10437-106E5	164.22	37.82
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	100.84	15.07
paracentral gyrus, adult, pool1	10035-101E8	76.97	54.18
parietal cortex, adult, donor10258	10373-105G4	79.27	52.11
parietal lobe - adult, donor10196	10171-103B9	86.52	62.07
parietal lobe, adult, donor10252	10157-103A4	66.41	58.72
parietal lobe, adult, pool1	10034-101E7	65.21	59.30
parietal lobe, fetal, donor1	10072-101I9	69.83	39.76
parietal lobe, newborn, donor10223	10356-105E5	65.43	72.15
parotid gland, adult	10199-103F1	46.87	17.27
penis, adult	10200-103F2	66.06	27.93
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	134.99	21.57
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	93.24	17.77
pineal gland - adult, donor10196	10179-103C8	78.69	30.96
pineal gland, adult, donor10252	10160-103A7	146.87	33.76
pineal gland, adult, donor10258	10377-105G8	102.21	50.17
pituitary gland - adult, donor10196	10180-103C9	52.61	22.26
pituitary gland, adult, donor10252	10162-103A9	59.94	21.37
pituitary gland, adult, donor10258	10378-105G9	44.26	24.69
placenta, adult, pool1	10021-101D3	52.89	22.15
plasma cell leukemia cell line:ARH-77	10840-111E3	227.11	44.23
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	112.68	44.20
pons, adult, pool1	10033-101E6	82.45	75.40
postcentral gyrus, adult, pool1	10032-101E5	63.29	47.60
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	66.10	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00
prostate cancer cell line:DU145	10490-107B4	240.49	54.48
prostate cancer cell line:PC-3	10439-106E7	231.60	73.51
prostate, adult, pool1	10022-101D4	75.18	31.56
putamen, adult, donor10196	10176-103C5	74.12	80.97
putamen, adult, donor10252	10152-102I8	74.51	41.18
putamen, adult, donor10258, tech_rep1	10372-105G3	173.76	57.92
putamen, adult, donor10258, tech_rep2	10372-105G3	61.61	68.62
putamen, newborn, donor10223	10365-105F5	60.72	53.98
rectal cancer cell line:TT1TKB	10469-106I1	106.77	25.89
rectum, fetal, donor1	10067-101I4	114.06	50.08
renal cell carcinoma cell line:OS-RC-2	10411-106B6	94.98	9.75
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	104.80	3.31
retina, adult, pool1	10030-101E3	73.75	25.05
retinoblastoma cell line:Y79	10475-106I7	282.66	43.39
rhabdomyosarcoma cell line:KYM-1	10787-110H4	160.94	43.52
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	214.27	37.68
sacrococcigeal teratoma cell line:HTST	10695-109G2	53.81	10.61
salivary acinar cells, donor1	11771-123I7	57.78	26.22
salivary acinar cells, donor2	11772-123I8	45.16	17.90
salivary acinar cells, donor3	11773-123I9	33.10	13.24
salivary gland, adult, pool1	10093-102C3	46.90	14.87
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	109.35	22.26
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	114.97	27.39
seminal vesicle, adult	10201-103F3	54.49	40.21
serous adenocarcinoma cell line:JHOS-2	10639-108I9	89.40	28.67
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	98.14	24.66
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	167.59	41.14
serous cystadenocarcinoma cell line:HTOA	10693-109F9	119.95	53.86
signet ring carcinoma cell line:Kato III	10436-106E4	190.33	32.94
signet ring carcinoma cell line:NUGC-4	10483-107A6	67.48	18.71
skeletal muscle - soleus muscle, donor1	10282-104F3	64.55	28.37
skeletal muscle, adult, pool1	10023-101D5	79.28	39.34
skeletal muscle, fetal, donor1	10066-101I3	46.23	43.22
skin, adult, donor1	10074-102A2	27.14	54.28
skin, fetal, donor1	10065-101I2	78.90	49.24
small cell cervical cancer cell line:HCSC-1	10800-110I8	186.77	60.37
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	168.00	43.18
small cell lung carcinoma cell line:DMS 144	10841-111E4	390.12	95.22
small cell lung carcinoma cell line:LK-2	10541-107H1	190.38	46.81
small cell lung carcinoma cell line:NCI-H82	10842-111E5	156.19	19.62
small cell lung carcinoma cell line:WA-hT	10562-108A4	115.50	20.27
small intestine, adult, pool1	10024-101D6	146.91	137.84
small intestine, fetal, donor1	10064-101I1	76.41	19.41
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	53.85	6.15
smooth muscle, adult, pool1	10048-101G3	64.10	24.29
somatostatinoma cell line:QGP-1	10781-110G7	38.06	8.31
spinal cord - adult, donor10196	10181-103D1	75.02	66.53
spinal cord, adult, donor10252	10159-103A6	70.57	54.02
spinal cord, adult, donor10258	10369-105F9	109.30	50.50
spinal cord, fetal, donor1	10056-101H2	73.79	60.98
spinal cord, newborn, donor10223	10359-105E8	90.92	60.62
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	63.62	20.61
spleen, adult, pool1	10025-101D7	62.23	25.11
spleen, fetal, pool1	10044-101F8	41.08	16.21
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	79.50	23.29
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	132.34	26.39
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	122.31	33.90
squamous cell carcinoma cell line:T3M-5	10616-108G4	80.14	13.29
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	100.85	18.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	261.79	49.99
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	266.53	73.19
stomach, fetal, donor1	10062-101H8	69.42	19.22
submaxillary gland, adult	10202-103F4	42.73	19.94
substantia nigra - adult, donor10196	10178-103C7	108.55	162.82
substantia nigra, adult, donor10252	10158-103A5	51.30	46.73
substantia nigra, adult, donor10258	10371-105G2	99.31	58.45
substantia nigra, newborn, donor10223	10358-105E7	63.59	52.29
synovial sarcoma cell line:HS-SY-II	10441-106E9	182.72	60.76
temporal lobe, adult, pool1	10031-101E4	51.46	33.74
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	49.86	24.93
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	36.92	18.90
tenocyte, donor1	11763-123H8	71.57	21.99
tenocyte, donor2	11765-123I1	49.60	25.94
tenocyte, donor3	11768-123I4	61.90	24.83
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	303.72	61.36
teratocarcinoma cell line:NCR-G1	10798-110I6	194.23	74.15
teratocarcinoma cell line:PA-1	10807-111A6	253.08	45.41
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	153.35	58.90
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	247.70	37.44
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	161.30	58.89
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	160.90	47.88
testis, adult, pool1	10026-101D8	49.71	27.17
testis, adult, pool2	10096-102C6	35.18	24.36
thalamus - adult, donor10196	10168-103B6	71.76	46.37
thalamus, adult, donor10252	10154-103A1	56.57	45.48
thalamus, adult, donor10258, tech_rep1	10370-105G1	144.72	70.82
thalamus, adult, donor10258, tech_rep2	10370-105G1	55.99	50.56
thalamus, newborn, donor10223	10366-105F6	86.87	60.41
throat, adult	10209-103G2	65.91	33.21
throat, fetal, donor1	10061-101H7	67.34	40.83
thymic carcinoma cell line:Ty-82	10803-111A2	318.96	91.02
thymus, adult, pool1	10027-101D9	59.45	16.80
thymus, fetal, pool1	10043-101F7	50.60	20.16
thyroid carcinoma cell line:KHM-5M	10776-110G2	180.16	41.22
thyroid carcinoma cell line:TCO-1	10783-110G9	186.21	38.28
thyroid, adult, pool1	10028-101E1	96.02	34.71
thyroid, fetal, donor1	10060-101H6	66.71	29.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	21.56
tongue, adult	10203-103F5	83.26	49.31
tongue, fetal, donor1	10059-101H5	94.19	65.81
tonsil, adult, pool1	10047-101G2	63.01	20.64
trachea, adult, pool1	10029-101E2	52.76	18.00
trachea, fetal, donor1	10058-101H4	67.71	25.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	81.84	17.36
transitional-cell carcinoma cell line:5637	10418-106C4	106.58	30.19
transitional-cell carcinoma cell line:JMSU1	10492-107B6	197.27	34.31
tridermal teratoma cell line:HGRT	10694-109G1	79.91	17.12
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	73.48	24.46
umbilical cord, fetal, donor1	10057-101H3	81.37	33.38
uterus, adult, pool1	10100-102D1	88.21	27.13
uterus, fetal, donor1	10055-101H1	114.67	58.36
vagina, adult	10204-103F6	38.13	19.39
vein, adult	10191-103E2	49.10	15.56
xeroderma pigentosum b cell line:XPL 17	10563-108A5	77.97	20.56